AVEO Pharmaceuticals, Inc.
34 clinical trials · Sponsor
◉ Watch AVEO Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma (NCT06064877) | AVEO Pharmaceuticals, Inc. | 2024-01-11 |
| A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia (NCT05865535) | AVEO Pharmaceuticals, Inc. | 2023-06-13 |
| A Phase 1 Study of AV-380 in Healthy Subjects (NCT04815551) | AVEO Pharmaceuticals, Inc. | 2021-02-22 |
| A Study of Ficlatuzumab With HiDAC and HiDAC Alone in Adults With Relapsed or Refractory Acute Myeloid Leukemia (NCT04100330) | AVEO Pharmaceuticals, Inc. | 2020-01-31 |
| A Study of Tivozanib in Combination With Durvalumab in Subjects With Advanced Hepatocellular Carcinoma (NCT03970616) | AVEO Pharmaceuticals, Inc. | 2019-09-30 |
Track AVEO Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.